TalkMed Group

SINGAPORE (Feb 19): TalkMed Group posted a 16.4% increase in earnings to $9.6 million for the 4Q18 ended December, from $8.2 million a year ago.

SINGAPORE (May 23): Stocks of the 15 largest Singapore-listed healthcare equipment and services companies with market caps above $100 million, have gained an average 9.2% year to date, according to data from the Singapore Exchange.

SINGAPORE (Apr 24): TalkMed Group, which provides private healthcare services in the fields of medical oncology through Parkway Cancer Centre in Singapore, reported a 37.2% fall in first quarter earnings to $5.06 million in 1Q18 from $8.39 million in 1Q17

SINGAPORE (Feb 20): TalkMed Group reported 4Q17 earnings fell 19.3% to $8.2 million from $10.2 million a year ago mainly due to a decrease in revenue.

SINGAPORE (Jan 8): Although healthcare stocks in Singapore underperformed last year largely due to the setting up of new hospitals overseas, CIMB says the sector would be rerated once they stabilised.

SINGAPORE (Jan 8): CIMB is maintaining its “hold” call on TalkMed Group with a lower target price of 68 cents from 92 cents previously, after cutting FY17-19F earnings per share (EPS) estimates by 18-21% to factor anticipated earnings losses from the

SINGAPORE (Nov 7): Healthcare company TalkMed Group posts a 17.2% decline in earnings to $7.1 million in the 3Q ended September, from $8.6 million a year ago.

SINGAPORE (Sept 27): New entrants UnUsUaL and Kimly now maintain the two highest weights on the FTSE ST Catalist Index, at 6% and 5% respectively.

SINGAPORE (Aug 25): Dr Ang Peng Tiam renowned oncologist and CEO of TalkMed Group specialises in treatment and palliative care for people suffering from cancer.

SINGAPORE (June 29): RHB is maintaining its “buy” call on TalkMed Group with a lower target price of 73 cents from $1.03 previously following Wednesday’s news of the eight-month suspension of its CEO, Dr Ang Peng Tiam, starting from July 25.